Concepedia

Diansheng Zhong

DZ

Statistics

Publications

8

Citations

343

H-Index

8

Active since

2016

Affiliations

Tianjin Medical University General Hospital(Current)

Central South University

Tianjin Medical University Cancer Institute and Hospital

Xinjiang Medical University

Peking University

Diansheng Zhong is an author at Tianjin Medical University General Hospital specializing in oncology, pharmacology, and medicine.

ORCID

Publications per year

2016–2025

8

Publications

8

Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

Ying Cheng, Jianhua Chen, Wei Zhang et al. · Nature Medicine · 2024 · 121 citations · Full text

, , +16

First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial

Lin Shen, Yanqiao Zhang, Ziyu Li et al. · Nature Medicine · 2025 · 81 citations

, , +11

Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors <i>via</i> the transporter ASCT2

Ping Zhou, Xingmei Liang, Ce Zhou et al. · Journal of Materials Chemistry B · 2019 · 33 citations

, , +16

Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity

Shuang Zheng, Jiaming Song, Dongli Linghu et al. · International Journal of Biological Sciences · 2023 · 33 citations · Full text

, , +17

2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells

Linlin Sun, Xiuju Liu, Haian Fu et al. · PLoS ONE · 2016 · 27 citations · Full text

, , +17

1–5 of 8